Quest Diagnostics
(NYSE:DGX)
$128.14
-0.14[-0.11%]
At close: Mar 18
$128.14
0[0.00%]
After Hours: 4:00PM EDT

GET A REPORT ON DGX SENT RIGHT TO YOUR INBOX

Quest Diagnostics Stock (NYSE:DGX), Analyst Ratings, Price Targets, Predictions

Analysts publish ratings and price targets on most stocks. Benzinga tracks 120 analyst firms so investors can understand if analysts expect a stock to trade higher or lower. Ratings are directional and typically buy, sell or hold. Price Targets are an analyst's best guess at where the stock will trade in 12 months.
Consensus Rating1
Neutral
Highest Price Target1
$170.00
Lowest Price Target1
$135.00
Consensus Price Target1
$150.30

Analyst Rating Summary1

Analyst Ratings
Oct 23
2
Nov 23
2
Dec 23
1
2
Feb
1
1
Strong Buy
Buy
Hold
Sell
Strong Sell

Analyst Firms Making Recommendations1

Leerink Partners
Jefferies
Truist Securities
B of A Securities
Citigroup

1calculated from analyst ratings published within the last 3 years

Analyst Ratings for Quest Diagnostics

date
ticker
Buy Now
Company
Current price
Upside/Downside
Analyst Firm
Analyst & % Accurate
Price Target Change
Rating Change
Previous / Current Rating
Get Alert
02/26/2024DGXBuy Now
Quest Diagnostics
$128.145.35%Leerink Partners
Michael Cherny
→ $135Initiates → Market PerformGet Alert
02/07/2024DGXBuy Now
Quest Diagnostics
$128.1420.96%Jefferies
Brian Tanquilut
$140 → $155UpgradeHold → BuyGet Alert
02/02/2024DGXBuy Now
Quest Diagnostics
$128.1413.16%Truist Securities
David Macdonald
$150 → $145MaintainsHoldGet Alert
12/20/2023DGXBuy Now
Quest Diagnostics
$128.1417.06%Truist Securities
David Macdonald
$145 → $150MaintainsHoldGet Alert
12/12/2023DGXBuy Now
Quest Diagnostics
$128.1424.86%B of A Securities
Derik De Bruin
$140 → $160UpgradeNeutral → BuyGet Alert
12/11/2023DGXBuy Now
Quest Diagnostics
$128.1413.16%Citigroup
Patrick Donnelly
$130 → $145MaintainsNeutralGet Alert
12/07/2023DGXBuy Now
Quest Diagnostics
$128.146.91%UBS
Kevin Caliendo
$135 → $137MaintainsNeutralGet Alert
11/17/2023DGXBuy Now
Quest Diagnostics
$128.1416.28%JP Morgan
John Stansel
$148 → $149MaintainsNeutralGet Alert
11/06/2023DGXBuy Now
Quest Diagnostics
$128.149.26%Piper Sandler
David Westenberg
$130 → $140MaintainsNeutralGet Alert
10/25/2023DGXBuy Now
Quest Diagnostics
$128.141.45%Citigroup
Patrick Donnelly
$142 → $130MaintainsNeutralGet Alert
10/16/2023DGXBuy Now
Quest Diagnostics
$128.141.45%Piper Sandler
David Westenberg
$145 → $130MaintainsNeutralGet Alert
08/03/2023DGXBuy Now
Quest Diagnostics
$128.1413.16%Morgan Stanley
Ricky Goldwasser
$145 → $145ReiteratesEqual-Weight → Equal-WeightGet Alert
06/29/2023DGXBuy Now
Quest Diagnostics
$128.1413.16%Piper Sandler
David Westenberg
→ $145Initiates → NeutralGet Alert
05/10/2023DGXBuy Now
Quest Diagnostics
$128.1413.16%Morgan Stanley
Ricky Goldwasser
$158 → $145MaintainsEqual-WeightGet Alert
05/02/2023DGXBuy Now
Quest Diagnostics
$128.1415.5%B of A Securities
Derik De Bruin
$166 → $148DowngradeBuy → NeutralGet Alert
04/03/2023DGXBuy Now
Quest Diagnostics
$128.1410.82%Citigroup
Patrick Donnelly
$125 → $142UpgradeSell → NeutralGet Alert
03/17/2023DGXBuy Now
Quest Diagnostics
$128.1424.86%Truist Securities
David Macdonald
$170 → $160MaintainsHoldGet Alert
03/17/2023DGXBuy Now
Quest Diagnostics
$128.1428.77%Mizuho
Ann Hynes
→ $165Reiterates → BuyGet Alert
02/03/2023DGXBuy Now
Quest Diagnostics
$128.149.26%Wells Fargo
Timothy Daley
$135 → $140MaintainsEqual-WeightGet Alert

FAQ

Q

What is the target price for Quest Diagnostics (DGX)?

A

The latest price target for Quest Diagnostics (NYSE: DGX) was reported by Leerink Partners on February 26, 2024. The analyst firm set a price target for $135.00 expecting DGX to rise to within 12 months (a possible 5.35% upside). 16 analyst firms have reported ratings in the last year.

Q

What is the most recent analyst rating for Quest Diagnostics (DGX)?

A

The latest analyst rating for Quest Diagnostics (NYSE: DGX) was provided by Leerink Partners, and Quest Diagnostics initiated their market perform rating.

Q

When is the next analyst rating going to be posted or updated for Quest Diagnostics (DGX)?

A

Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Quest Diagnostics, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Quest Diagnostics was filed on February 26, 2024 so you should expect the next rating to be made available sometime around February 26, 2025.

Q

Is the Analyst Rating Quest Diagnostics (DGX) correct?

A

While ratings are subjective and will change, the latest Quest Diagnostics (DGX) rating was a initiated with a price target of $0.00 to $135.00. The current price Quest Diagnostics (DGX) is trading at is $128.14, which is within the analyst’s predicted range.

Browse analyst ratings and price targets on all stocks.

People Also Watch